মহিলা মানুষ বয়স ৪০ এর ঘরে। ধরেন তার Diabetes ও আছে।
এই মহিলা যদি এখন Complain করে যে তার গা হাত পা জ্বালা পোড়া করে ।তাহলে আমাদের Differential Diagnosis দাড়ায় দুইটা।
১) Diabetic Neuropathy
2) Post menopausal Syndrome
এখন এটাকে Clinically Differentiate করবো কিভাবে?
: যদি রোগী বলে তার হাত আর পায়ের তালু জ্বালা পোড়া করে। তাহলে মনে করতে হবে Diabetic Neuropathy. সেক্ষেত্রে আমরা Pregabalin বা Tryptin দিতে পারি।
: আর যদি রোগী বলে যে আমার শরীরের উপরের দিক জ্বালাপোড়া করে। বিশেষ করে মাথার তালু,মুখ।তাহলে মনে করতে হবে It might be due to Post menopausal Syndrome.
সেক্ষেত্রে আমাদের রোগী কে Hormone replacement Therapy দিতে হবে। যেমন Tibolone 2.5 mg once daily. তবে Hormone Replacement Therapy দেবার আগে অবশ্যই আমাদের দুইটা investigation দেখা উচিৎ । একটা হলো Mammogram আর একটা TVS.
কারণ HRT এর কারনে দুইটা Malignancy হবার সম্ভাবনা বেশি থাকে।
১) Breast Cancer
2) Endometrial Cancer
HRT এর পরিবর্তে Non hormonal treatment হিসেবে New option Tab. Fezotan 45 mg দেওয়া যেতে পারে,যাতে Breast cancer, Endometrial cancer এর ঝুঁকি নাই বললেই চলে। Once daily for 6- 12 month
Tablet 1.Fezotan 45 mg
Indications:-
Fezotan tablet is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
Pharmacology:-
Fezolinetant is a neurokinin 3 (NK3) receptor antagonist that blocks neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron to modulate neuronal activity in the thermoregulatory center. Fezolinetant has high affinity for the NK3 receptor (Ki value of 19.9 to 22.1 nmol/L), which is more than 450-fold higher than binding affinity to NK1 or NK2 receptors.
Treatment with fezolinetant did not show any clear trends in sex hormones measured (follicle-stimulating hormone, testosterone, estrogen, and dehydroepiandrosterone sulfate) in menopausal women. Transient decrease of luteinizing hormone (LH) levels was observed at peak concentrations of fezolinetant.
Dosage & Administration:-
Take a single 45 mg Fezolinetant tablet orally once daily with or without food. Take Fezolinetant with liquids and swallow whole. Do not cut, crush, or chew tablets. Administer Fezolinetant orally at about the same time each day. If a dose of Fezolinetant is missed or not taken at the usual time, administer the missed dose as soon as possible, unless there is less than 12 hours before the next scheduled dose. Return to the regular schedule the following day.
Pediatric Use: The efficacy and safety of Fezolinetant in individuals less than 18 years of age have not been established.
Geriatric Use: There have not been sufficient numbers of geriatric women involved in clinical trials utilizing Fezolinetant to determine whether those over 65 years of age differ from younger women in their response to Fezolinetant.
Side Effects:-
Common side efects of Fezotan include:
- stomach (abdominal) pain
- diarrhea
- difculty sleeping
- back pain
- hot fashes or hot fushes
Stop Fezotan if you have the following signs or symptoms of liver problems:
- nausea
- vomiting
- itching
- yellowing of the eyes or skin (jaundice)
- pale feces
- dark urine
- pain in the right upper stomach (abdomen)
Burning sensation in a 40+ diabetic woman — important differentials
আপনি যেভাবে দুইটা প্রধান differential ধরেছেন, সেটা clinically খুব common:
- Diabetic Peripheral Neuropathy (DPN)
- Perimenopausal/Postmenopausal vasomotor syndrome
তবে শুধু location দিয়ে differentiate করা যথেষ্ট না। Clinical pattern + examination + associated symptoms একসাথে দেখতে হবে।
১) Diabetic Neuropathy — Clinical Clues
Typical symptoms
- Burning feet
- Tingling / numbness
- “Pins and needles”
- Electric shock–like pain
- Night worsening
- Glove and stocking distribution
সবচেয়ে common:
- পায়ের পাতায় শুরু হয়
- পরে হাত জড়ায়
Distribution
সবচেয়ে characteristic:
- Distal symmetrical pattern
- Sole, toes, feet → gradually upward
Examination findings
- Reduced vibration sense
- Reduced ankle jerk
- Decreased pinprick sensation
- Monofilament abnormal
Associated history
- Long-standing diabetes
- Poor glycemic control
- Retinopathy / nephropathy থাকতে পারে
Treatment
First-line options:
- Pregabalin
- Gabapentin
- Duloxetine (Suggested)
- Amitriptyline (Tryptin)
Example
Pregabalin 75 mg HS → titrate
বা
Amitriptyline 10–25 mg HS
২) Perimenopausal / Postmenopausal Syndrome
এখানে “burning” usually neuropathic burning না।
বরং:
- Hot flush
- Heat sensation
- Facial flushing
- Scalp warmth
- Upper body warmth
- Sweating
Typical age
- Usually >45 years
- Menstrual irregularity থাকে
Associated symptoms
খুব important:
- Amenorrhea / irregular cycle
- Hot flush
- Night sweats
- Mood change
- Vaginal dryness
- Sleep disturbance
- Reduced libido
Distribution
More commonly:
- Face
- Neck
- Chest
- Scalp
- Upper torso
এটা neuropathy pattern না।
Practical Clinical Differentiation
| Feature | Diabetic Neuropathy | Menopausal Syndrome |
| Site | Feet/soles ± hands | Face, scalp, chest |
| Pattern | Glove & stocking | Hot flush pattern |
| Nature | Burning + numbness | Heat/flushing/sweating |
| Worse at | Night | Sudden episodes |
| Neuro deficit | Present | Absent |
| Menstrual symptoms | Usually absent | Present |
| Sweating/flushing | No | Common |
Important Correction About HRT
আপনি লিখেছেন:
HRT দিলে Breast cancer ও Endometrial cancer হওয়ার সম্ভাবনা বেশি থাকে
এটা partially true but oversimplified.
Actually:
Endometrial cancer risk ↑
- Mainly with unopposed estrogen therapy
- Especially if uterus intact
তাই uterus থাকলে:
- Estrogen + progesterone combination দিতে হয়
Breast cancer risk
- Long-term combined HRT use এ risk slightly increases
- Short-term appropriate HRT generally acceptable after risk assessment
Before Starting HRT — Evaluation
আপনার Mammogram + TVS point clinically reasonable।
Common baseline assessment:
- Breast examination
- Mammography (age/risk dependent)
- TVS if abnormal bleeding
- BP
- BMI
- VTE risk
- Cardiovascular risk
সব patient এ routine TVS mandatory না unless:
- Abnormal uterine bleeding
- Endometrial concern
Important Correction About Fezolinetant
আপনি “Fezotan” লিখেছেন — সম্ভবত আপনি Fezolinetant বুঝিয়েছেন।
Fezolinetant
- Neurokinin-3 receptor antagonist
- Used for moderate–severe vasomotor symptoms (hot flush)
Advantage
- Non-hormonal
- Does NOT stimulate endometrium like estrogen
- Breast cancer risk comparatively lower than HRT
But important:
“ঝুঁকি নাই বললেই চলে” — এভাবে বলা ঠিক না।
No drug is completely risk-free.
Liver monitoring may be needed.
Clinically safest approach
If burning is:
Distal feet dominant + numbness
→ Think diabetic neuropathy first
If:
Hot flush + sweating + menstrual irregularity
→ Think perimenopause/menopause
কিন্তু remember:
একই patient এর দুইটাই একসাথে থাকতে পারে।
Evidence-Based References
Harrison’s Principles of Internal Medicine, 21st Edition
- Chapter 417: Diabetic Neuropathy
- Chapter 403: Menopause and Perimenopausal Hormone Therapy
Davidson’s Principles & Practice of Medicine, 24th Edition
- Chapter: Diabetes Mellitus and Hypoglycaemia
- Chapter: Menopause and HRT
Williams Gynecology, 5th Edition
- Chapter: Menopause
NICE Guideline NG23
- Menopause: diagnosis and management
ADA Standards of Care 2026
- Diabetic neuropathy management
Md.Rafiqul Islam Lipu,Date:-07-05-2026 Thursday Time:-10-52-27 Pm